Gofen & Glossberg’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.48M | Buy |
120,286
+952
| +0.8% | +$71.4K | 0.24% | 95 |
|
|
2022
Q3 | $8.38M | Sell |
119,334
-149
| -0.1% | -$11.7K | 0.24% | 95 |
|
|
2022
Q2 | $9.57M | Sell |
119,483
-3,398
| -3% | -$266K | 0.25% | 92 |
|
|
2022
Q1 | $9.32M | Sell |
122,881
-7,764
| -6% | -$615K | 0.21% | 102 |
|
|
2021
Q4 | $11.1M | Sell |
130,645
-1,803
| -1% | -$141K | 0.24% | 95 |
|
|
2021
Q3 | $10M | Sell |
132,448
-4,445
| -3% | -$353K | 0.23% | 95 |
|
|
2021
Q2 | $11.1M | Sell |
136,893
-1,349
| -1% | -$110K | 0.26% | 89 |
|
|
2021
Q1 | $10.9M | Sell |
138,242
-961
| -0.7% | -$75.3K | 0.28% | 83 |
|
|
2020
Q4 | $11.9M | Sell |
139,203
-1,400
| -1% | -$116K | 0.33% | 75 |
|
|
2020
Q3 | $10.8M | Sell |
140,603
-907
| -0.6% | -$69.2K | 0.33% | 72 |
|
|
2020
Q2 | $10.4M | Sell |
141,510
-1,775
| -1% | -$126K | 0.35% | 71 |
|
|
2020
Q1 | $9.51M | Sell |
143,285
-4,395
| -3% | -$310K | 0.37% | 68 |
|
|
2019
Q4 | $10.2M | Sell |
147,680
-769
| -0.5% | -$52.4K | 0.32% | 78 |
|
|
2019
Q3 | $10.9M | Buy |
148,449
+6,981
| +5% | +$506K | 0.37% | 71 |
|
|
2019
Q2 | $10.1M | Sell |
141,468
-6,811
| -5% | -$484K | 0.35% | 74 |
|
|
2019
Q1 | $10.2M | Sell |
148,279
-1,544
| -1% | -$99.7K | 0.36% | 73 |
|
|
2018
Q4 | $8.92M | Sell |
149,823
-330
| -0.2% | -$20.6K | 0.35% | 76 |
|
|
2018
Q3 | $10.1M | Sell |
150,153
-325
| -0.2% | -$21.6K | 0.35% | 79 |
|
|
2018
Q2 | $9.75M | Sell |
150,478
-2,664
| -2% | -$174K | 0.36% | 76 |
|
|
2018
Q1 | $11M | Sell |
153,142
-2,325
| -1% | -$167K | 0.41% | 73 |
|
|
2017
Q4 | $11.7M | Sell |
155,467
-2,223
| -1% | -$162K | 0.42% | 73 |
|
|
2017
Q3 | $11.5M | Sell |
157,690
-1,217
| -0.8% | -$87.7K | 0.43% | 72 |
|
|
2017
Q2 | $11.8M | Sell |
158,907
-1,173
| -0.7% | -$87.1K | 0.45% | 70 |
|
|
2017
Q1 | $11.7M | Sell |
160,080
-5,663
| -3% | -$396K | 0.46% | 67 |
|
|
2016
Q4 | $10.8M | Sell |
165,743
-1,748
| -1% | -$120K | 0.44% | 69 |
|
|
2016
Q3 | $12.4M | Sell |
167,491
-2,146
| -1% | -$159K | 0.52% | 64 |
|
|
2016
Q2 | $12.4M | Sell |
169,637
-458
| -0.3% | -$32.6K | 0.52% | 63 |
|
|
2016
Q1 | $12M | Sell |
170,095
-2,040
| -1% | -$136K | 0.51% | 63 |
|
|
2015
Q4 | $11.5M | Sell |
172,135
-2,397
| -1% | -$159K | 0.5% | 65 |
|
|
2015
Q3 | $11.1M | Sell |
174,532
-3,435
| -2% | -$224K | 0.5% | 64 |
|
|
2015
Q2 | $11.6M | Buy |
177,967
+328
| +0.2% | +$22.3K | 0.49% | 63 |
|
|
2015
Q1 | $12.3M | Sell |
177,639
-3,199
| -2% | -$221K | 0.53% | 56 |
|
|
2014
Q4 | $12.5M | Sell |
180,838
-1,021
| -0.6% | -$69K | 0.54% | 59 |
|
|
2014
Q3 | $11.9M | Sell |
181,859
-2,028
| -1% | -$134K | 0.52% | 60 |
|
|
2014
Q2 | $12.5M | Sell |
183,887
-1,392
| -0.8% | -$93.3K | 0.55% | 57 |
|
|
2014
Q1 | $11.6M | Buy |
185,279
+6,257
| +3% | +$394K | 0.54% | 58 |
|
|
2013
Q4 | $11.7M | Sell |
179,022
-2,364
| -1% | -$151K | 0.55% | 57 |
|
|
2013
Q3 | $10.8M | Sell |
181,386
-1,258
| -0.7% | -$74.5K | 0.55% | 58 |
|
|
2013
Q2 | $10.5M | Buy |
+182,644
| New | +$10.8M | 0.57% | 55 |
|
Other funds holding CL
TP
Gofen & Glossberg's CL Position: Q4 2022 in Review
Gofen & Glossberg increased its Colgate-Palmolive (CL) stake by 0.8% in Q4 2022, buying an estimated $71.4K and bringing the position to 120,286 shares worth $9.48M. The position accounts for 0.24% of the portfolio, ranked #95.
Gofen & Glossberg first reported a position in CL in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.5M in Q2 2014. 1,699 funds tracked by Wall St. Rank hold CL as of Q4 2022.
- Gofen & Glossberg held 120,286 shares of Colgate-Palmolive worth $9.48M as of Q4 2022.
- Gofen & Glossberg bought 952 Colgate-Palmolive shares in Q4 2022, an estimated $71.4K.
- Colgate-Palmolive made up 0.24% of Gofen & Glossberg's portfolio in Q4 2022, its #95 holding.
- Gofen & Glossberg first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Colgate-Palmolive position peaked at $12.5M in Q2 2014.
- 1,699 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.